Webcast CME

Series Activities

Series Menu

Primary Vasculitides: Best Practices and Future Advances


GPA and MPA: Future Outlook

Print this Content

Release Date:   June 12, 2017
Expiration Date:   June 12, 2019

Estimated Time of Completion:   45 minutes

Description

Cleveland Clinic R.J. Fasenmyer Center for Clinical Immunology presents Primary Vasculitides: Best Practices and Future Advances online series featuring an update on the current standard of care and management of patients with primary vasculitides. Advances and future development in the treatment of primary vasculitides will be shared by the experts in this field.

This webcast will review the management of GPA and MPA, as well as ongoing clinical trials addressing unmet needs. The future director of research efforts in the field of ANC-associated vasculitis will also be discussed.

Learning Objectives

  1. Review unmet needs in the management of GPA and MPA.
  2. Describe ongoing clinical trials addressing unmet needs in GPA and MPA.
  3. Discuss the direction of future research efforts in the field of ANCA-associated vasculitis.

Target Audience

This online series is directed towards rheumatologists, nephrologists, pulmonologists, dermatologists, neurologists, allergists, immunologists, and advanced practice clinicians interested in vasculitis.

Accreditation

The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Cleveland Clinic Foundation Center for Continuing Education designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association for Category 2 credit.

Activity Directors and Faculty

Activity Directors

Leonard H. Calabrese, DO
Professor of Medicine
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
R.J. Fasenmyer Chair of Clinical Immunology
Department of Rheumatic and Immunologic Diseases
Orthopaedic and Rheumatologic Institute
Cleveland Clinic
Cleveland, OH

Rula Hajj-Ali, MD
Associate Professor of Medicine
Cleveland Clinic Lerner College of Medicine
Associate Director, Center for Vasculitis Care and Research
Department of Rheumatic and Immunologic Diseases
Orthopaedic and Rheumatologic Institute
Cleveland Clinic
Cleveland, OH

Carol Langford, MD, MHS
Harold C. Schott Endowed Chair in Rheumatic and Immunologic Diseases
Director, Center for Vasculitis Care and Research
Department of Rheumatic and Immunologic Diseases
Orthopaedic and Rheumatologic Institute
Cleveland Clinic
Cleveland, OH

Faculty

Ulrich Specks, MD
Professor of Medicine
Chair, Pulmonary and Critical Care Medicine
Mayo Clinic
Rochester, MN

CME Disclaimer

The information in this educational activity is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient's medical condition. The viewpoints expressed in this CME activity are those of the authors/faculty. They do not represent an endorsement by The Cleveland Clinic Foundation. In no event will The Cleveland Clinic Foundation be liable for any decision made or action taken in reliance upon the information provided through this CME activity.

Disclosures

In accordance with the Standards for Commercial Support issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Foundation Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are free of commercial bias.

The following faculty have indicated that they may have a relationship which, in the context of their presentation, could be perceived as a potential conflict of interest:


Leonard H. Calabrese, DO
  AbbVie Pharmaceuticals; Bristol Myers Squibb;
Genentech/ Roche; Janssen
Consulting; Teaching and Speaking
  GlaxoSmithKline; Pfizer, Inc.; Sanofi Aventis; UCB Consulting
  Crescendo Teaching and Speaking
Carol Langford, MD, MHS
  Bristol-Myers Squibb Co.; Genentech; GlaxoSmithKline Clinical trial funding support

The following faculty have indicated that they have no relationship which, in the context of their presentation, could be perceived as a potential conflict of interest:

Rula Hajj-Ali, MD
Ulrich Specks, MD

The Cleveland Clinic Foundation Center for Continuing Education
acknowledges educational grants for partial support of this activity from:

Genentech
Vasculitis Foundation

This CME activity was produced by the Cleveland Clinic Foundation Center for Continuing Education
and the R.J. Fasenmyer Center for Clinical Immunology.